Scholarlink

<p>Late-preterm infants (34–36+6 weeks' gestation) face increased risks of neurodevelopmental, metabolic, gastrointestinal, and immunologic complications due to incomplete late-gestation maturation. Mother's own milk (MOM) delivers unique bioactive factors that promote brain development, gut maturation, immunity, and lean growth—benefits superior to donor human milk or formula. Despite barriers such as feeding immaturity and routine supplementation, proactive lactation support can significantly improve MOM provision. This correspondence urges clinicians to prioritize MOM as the default feeding strategy in late-preterm care to enhance short- and long-term outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prioritizing mother’s own milk as essential therapy for late-preterm infants: a call for neonatal clinical action

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月25日

查看全文
  • Rakesh Kotha

摘要

Late-preterm infants (34–36+6 weeks' gestation) face increased risks of neurodevelopmental, metabolic, gastrointestinal, and immunologic complications due to incomplete late-gestation maturation. Mother's own milk (MOM) delivers unique bioactive factors that promote brain development, gut maturation, immunity, and lean growth—benefits superior to donor human milk or formula. Despite barriers such as feeding immaturity and routine supplementation, proactive lactation support can significantly improve MOM provision. This correspondence urges clinicians to prioritize MOM as the default feeding strategy in late-preterm care to enhance short- and long-term outcomes.